The gene 0610007N19Rik, encoded within the mouse genome, plays a crucial role in the intricate web of cellular functions, though its precise biological significance remains an area of active research. The expression of genes like 0610007N19Rik is subject to a complex network of regulatory controls that ensure the appropriate levels of protein are produced according to the cell's needs. These regulatory mechanisms involve a multitude of processes, including transcriptional control, mRNA stabilization, and epigenetic modifications. To understand and potentially modulate the expression of 0610007N19Rik, scientists explore various chemicals that can exert influence over these regulatory pathways. For instance, compounds that interact with the epigenetic landscape of the gene can lead to alterations in expression without changing the underlying DNA sequence. DNA methylation inhibitors, such as 5-Azacytidine and Decitabine, can cause hypomethylation of gene promoter regions, potentially downregulating gene activity by changing the accessibility of the DNA to transcriptional machinery.
Furthermore, chemicals that target histone modification enzymes also present a method to decrease the expression of genes like 0610007N19Rik. Histone deacetylase inhibitors, such as Trichostatin A and Vorinostat, can lead to changes in chromatin structure, rendering the associated DNA less amenable to transcriptional activation. Other agents, like Mithramycin A, which binds to specific DNA sequences, can block the interaction between DNA and essential transcription factors, thus inhibiting the initiation of transcription. Additionally, transcription can be directly inhibited by compounds such as Actinomycin D, which intercalates into DNA and obstructs the advancement of RNA polymerase. Specific inhibitors of RNA polymerase II, like Alpha-amanitin and DRB (5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole), can also sharply reduce the synthesis of mRNA corresponding to 0610007N19Rik. While each of these chemicals provides an avenue to suppress the expression of 0610007N19Rik, their effects are subject to variability based on the cellular context and the presence of other regulatory factors. The use of these compounds in research settings offers valuable insights into gene expression modulation, enhancing our understanding of the genetic machinery that orchestrates the complex symphony of life at the molecular level.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
Could demethylate promoter regions of the 0610007N19Rik gene, potentially leading to downregulation of its expression due to changes in transcriptional control. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
May inhibit histone deacetylase activity, leading to increased acetylation levels around the 0610007N19Rik locus, potentially resulting in the condensation of chromatin and decreased gene expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
By inhibiting DNA methyltransferases, it could specifically decrease methylation levels at the 0610007N19Rik promoter, and thereby reduce its transcription. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
May block histone deacetylases, resulting in a chromatin structure around the 0610007N19Rik gene that is less conducive to transcription, leading to reduced expression. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Could bind selectively to the GC-rich sequences in the promoter of 0610007N19Rik, preventing the binding of specific transcription factors necessary for its transcription initiation. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Might bind to double-stranded DNA, particularly at the transcription start site of 0610007N19Rik, obstructing RNA polymerase action and thereby inhibiting gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
This compound selectively inhibits RNA polymerase II, which is critical for the transcription of mRNA, including that of 0610007N19Rik, leading to decreased levels of the protein. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Although primarily affecting bacterial RNA polymerase, in a research context, it could be used to decrease 0610007N19Rik expression in prokaryotic systems engineered to express eukaryotic genes. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Could selectively inhibit RNA Polymerase II at the 0610007N19Rik gene, resulting in a targeted decrease in transcription. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
May inhibit the transcription of 0610007N19Rik by preventing the assembly of the transcription machinery at the gene′s promoter, leading to a decrease in mRNA synthesis. | ||||||